Our Latest News
Our Latest News
Our Latest News
New Success Story: Lys Therapeutics
New Success Story: Lys Therapeutics
New Success Story: Lys Therapeutics
Mar 12, 2026
Mar 12, 2026
Mar 12, 2026
INITS Chose Sartorius Bioreactors Technology for its disruptive bioproduction facility
INITS Chose Sartorius Bioreactors Technology for its disruptive bioproduction facility
INITS Chose Sartorius Bioreactors Technology for its disruptive bioproduction facility
Feb 26, 2026
Feb 26, 2026
Feb 26, 2026
AGS Therapeutics Advances Microalgae Extracellular Vesicles Manufacturing with INITS SMO!
AGS Therapeutics Advances Microalgae Extracellular Vesicles Manufacturing with INITS SMO!
AGS Therapeutics Advances Microalgae Extracellular Vesicles Manufacturing with INITS SMO!
Feb 16, 2026
Feb 16, 2026
Feb 16, 2026
New Success Story with Enterome!
New Success Story with Enterome!
New Success Story with Enterome!
Feb 10, 2026
Feb 10, 2026
Feb 10, 2026
INITS SMO and ALGA BIOLOGICS Join Forces to Pioneer GMP-Grade Monoclonal Antibody Production Using Microalgae
INITS SMO and ALGA BIOLOGICS Join Forces to Pioneer GMP-Grade Monoclonal Antibody Production Using Microalgae
INITS SMO and ALGA BIOLOGICS Join Forces to Pioneer GMP-Grade Monoclonal Antibody Production Using Microalgae
Feb 2, 2026
Feb 2, 2026
Feb 2, 2026
Partner Spotlight: Isofol Medical AB
Partner Spotlight: Isofol Medical AB
Partner Spotlight: Isofol Medical AB
Dec 3, 2025
Dec 3, 2025
Dec 3, 2025
Load More
Load More
© 2024 INITS. All rights reserved
© 2024 INITS. All rights reserved
© 2024 INITS. All rights reserved